Trials / Recruiting
RecruitingNCT06876805
The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
The Role of Contrast Enhanced Ultrasond (Ceus), in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to determine the accuracy of CEUS in characterizing (as benign or malignant) focal liver lesions for which CT, MRI and/or PET have not been conclusive.
Detailed description
The study conducted will be a non-profit, observational, non-pharmacological, cross-sectional, but also partly cohort, retrospective and prospective study. The study is cross-sectional in nature, but will require 6 months of follow-up to evaluate the gold standard reference outcome in patients diagnosed with a benign pathology that does not require further investigations, and in patients with suspected malignant lesion for which histological diagnosis has not been performed on biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | CEUS or Contrast enhanced Ultrasound | CEUS performed as normal clinical practice |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2026-08-01
- Completion
- 2027-04-01
- First posted
- 2025-03-14
- Last updated
- 2025-03-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06876805. Inclusion in this directory is not an endorsement.